SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-12-004246
Filing Date
2012-08-14
Accepted
2012-08-14 17:04:57
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT immy_10q.htm 10-Q 813839
2 CERTIFICATION immy_ex311.htm EX-31.1 17222
3 CERTIFICATION immy_ex312.htm EX-31.2 17602
4 CERTIFICATION immy_ex321.htm EX-32.1 6604
5 CERTIFICATION immy_ex322.htm EX-32.2 6831
  Complete submission text file 0001354488-12-004246.txt   3174141

Data Files

Seq Description Document Type Size
6 immy-20120630.xml EX-101.INS 308207
7 immy-20120630.xsd EX-101.SCH 30579
8 immy-20120630_cal.xml EX-101.CAL 39517
9 immy-20120630_lab.xml EX-101.LAB 224132
10 immy-20120630_pre.xml EX-101.PRE 153971
11 immy-20120630_def.xml EX-101.DEF 61885
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52998 | Film No.: 121034084
SIC: 2834 Pharmaceutical Preparations